AstraZeneca Covid-19 Vaccine 76% Effective in New Analysis of US Trial - News Femo

Latest news

Thursday, March 25, 2021

AstraZeneca Covid-19 Vaccine 76% Effective in New Analysis of US Trial

The latest data was based on 190 infections among more than 32,400 participants in the United States, Chile and Peru. AstraZeneca Covid-19 Vaccine 76% Effective in New Analysis of US Trial

No comments:

Post a Comment